Search Results 1011-1020 of 16991 for pharmacogenetics
The purpose of this study is to evaluate the feasibility of molecular characterization based on tumor mutational burden (TMB) for participant stratification ...
The purpose of this study is to show that human microbial communities are influenced by sleep and altered in humans with abnormal sleep patterns. They may ...
The purpose of this study is to estimate the proportion of Ventricular Assist Device (VAD) patients with abnormal gastrointestinal bleeding as assessed by ...
Dr. Miller's laboratory is experienced in all types of pharmacological, biochemical, cell biological and biophysical approaches to the characterization of ...
This is a placebo and active-controlled phase 2b dose-finding study to evaluate efficacy and safety of QGE031 monthly subcutaneous injections as add-on therapy ...
(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive. Print ...
This phase II trial studies how well denosumab works in treating patients with osteosarcoma that has come back (recurrent) or does not respond to treatment ( ...
The purpose of this study is to describe the hearing phenotype of individuals with mitochondrial disease and to determine if early investigation of hearing loss ...
About this study. The primary purpose of this study is to assess the effectiveness of a single intraoperative intravesical instillation of gemcitabine at ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.